Evidence map›Paper›PMID 33941065›Full record

ReviewBiochemistry. Biokhimiia2021

A Crosstalk between the Biorhythms and Gatekeepers of Longevity: Dual Role of Glycogen Synthase Kinase-3.

Gregory A Shilovsky, Tatyana S Putyatina, Galina V Morgunova, Alexander V Seliverstov, Vasily V Ashapkin, Elena V Sorokina, Alexander V Markov, Vladimir P Skulachev

Open access · bronzeAbstract readReview
In one paragraph

Review in Biochemistry. Biokhimiia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Review
  2. Review
  3. [Cannabidiol regulates circadian rhythm to improve sleep disorders following general anesthesia in rats].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  4. Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  5. The Change Rate of theBiology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gregory A ShilovskyBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. gregory_sh@list.ru.
Tatyana S PutyatinaFaculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Galina V MorgunovaFaculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Alexander V SeliverstovInstitute for Information Transmission Problems, Russian Academy of Sciences, Moscow, 127051, Russia.
Vasily V AshapkinBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia.
Elena V SorokinaFaculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Alexander V MarkovFaculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Vladimir P SkulachevBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia.
Lomonosov Moscow State University · RUInstitute for Information Transmission Problems · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review discusses genetic and molecular pathways that link circadian timing with metabolism, resulting in the emergence of positive and negative regulatory feedback loops. The Nrf2 pathway is believed to be a component of the anti-aging program responsible for the healthspan and longevity. Nrf2 enables stress adaptation by activating cell antioxidant defense and other metabolic processes via control of expression of over 200 target genes in response to various types of stress. The GSK3 system represents a "regulating valve" that controls fine oscillations in the Nrf2 level, unlike Keap1, which prevents significant changes in the Nrf2 content in the absence of oxidative stress and which is inactivated by the oxidative stress. Furthermore, GSK3 modifies core circadian clock proteins (Bmal1, Clock, Per, Cry, and Rev-erbα). Phosphorylation by GSK3 leads to the inactivation and degradation of circadian rhythm-activating proteins (Bmal1 and Clock) and vice versa to the activation and nuclear translocation of proteins suppressing circadian rhythms (Per and Rev-erbα) with the exception of Cry protein, which is likely to be implicated in the fine tuning of biological clock. Functionally, GSK3 appears to be one of the hubs in the cross-regulation of circadian rhythms and antioxidant defense. Here, we present the data on the crosstalk between the most powerful cell antioxidant mechanism, the Nrf2 system, and the biorhythm-regulating system in mammals, including the impact of GSK3 overexpression and knockout on the Nrf2 signaling. Understanding the interactions between the regulatory cascades linking homeostasis maintenance and cell response to oxidative stress will help in elucidating molecular mechanisms that underlie aging and longevity.

Indexed as

Circadian RhythmLongevityAgingAnimalsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansNF-E2-Related Factor 2Oxidative StressSignal TransductionGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaNF-E2-Related Factor 2agingaging programsanti-aging programsantioxidantsbiological rhythmsGSK3Nrf2oxidative stress

Identifiers

PMID33941065
PMCPMC8033555
OpenAlexW3154510730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.